Equip your team with the necessary tools to accurately anticipate coverage and predict post-launch access trajectory. Drawing from our extensive database of over 450 payers, this report combines interim coverage information of a new product prior to committee review with customized drug analogues.
Understand which payers will cover your drug at launch
Benchmark your new product coverage policies and customize your analysis by choosing at least one analogue to compare against
Understand which payers require prior authorization before formal product review
Forecast success of new product launches by segment and payer
Identify new drug coverage policies at the national and state level
Gain early wins by pinpointing pull-through opportunities with physicians
Payers’ new drug coverage policies describe how each plan will handle interim coverage of a new product before the P&T Committee reviews it. NPCA provides an analysis of a product analogue(s) to note any potential payer deviations from their stated new drug coverage policy.